Response to: The Long Game in Ulcerative Colitis: Mirikizumab's Four-Year Outcomes. Clemow DB. Inflamm Bowel Dis 2026 Apr 16:izag065. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clemow DB. Response to: The Long Game in Ulcerative Colitis: Mirikizumab's Four-Year Outcomes. Inflamm Bowel Dis 2026 Apr 16:izag065. doi: 10.1093.
PMID: 41988777